UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

1,2,4-Oxadiazole derivatives targeting EGFR and c-Met degradation in TKI resistant NSCLC

European journal of medicinal chemistry, 2019-11, Vol.182, p.111607-111607, Article 111607

2019

Volltextzugriff (PDF)

1,3‐diarylpyrazolones as potential anticancer agents for non‐small cell lung cancer: Synthesis and antiproliferative activity evaluation

Chemical biology & drug design, 2022-04, Vol.99 (4), p.620-633

2022

Volltextzugriff (PDF)

1‐Monopalmitin promotes lung cancer cells apoptosis through PI3K/Akt pathway in vitro

Environmental toxicology, 2023-11, Vol.38 (11), p.2621-2631

2023

Volltextzugriff (PDF)

1-n-heptyl-5-(3, 4-difluorophenyl) biguanide inhibits non-small cell lung cancer cell growth by downregulating the EGFR signaling pathways

American journal of translational research, 2021-01, Vol.13 (9), p.10193-10205

2021

Volltextzugriff (PDF)

1-o-acetylbritannilactone (ABL) inhibits angiogenesis and lung cancer cell growth through regulating VEGF-Src-FAK signaling

Biochemical and biophysical research communications, 2015-08, Vol.464 (2), p.422-427

2015

Volltextzugriff (PDF)

1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol treatment inhibits abnormal tumor growth by regulating neutrophil infiltration in a non-small cell lung carcinoma mouse model

Biomedicine & pharmacotherapy, 2024-09, Vol.178, p.117269, Article 117269

2024

Volltextzugriff (PDF)

A 10‐year prediagnostic follow‐up study shows that serum RNA signals are highly dynamic in lung carcinogenesis

Molecular oncology, 2020-02, Vol.14 (2), p.235-247

2020

Volltextzugriff (PDF)

125I Seed Brachytherapy Combined with Single-Agent Chemotherapy in the Treatment of Non-Small-Cell Lung Cancer in the Elderly: A Valuable Solution

OncoTargets and therapy, 2020, Vol.13, p.10581-10591

2020

Volltextzugriff (PDF)

14-3-3ζ promotes lung cancer cell invasion by increasing the Snail protein expression through atypical protein kinase C (aPKC)/NF-κB signaling

Experimental cell research, 2016-10, Vol.348 (1), p.1-9

2016

Volltextzugriff (PDF)

A 15-min premedication for 1-h paclitaxel infusion: Optimizing patients’ care

Lung cancer (Amsterdam, Netherlands), 2007-11, Vol.58 (2), p.300-301

2007

Volltextzugriff (PDF)

15 years single center experience with surgical resection of the superior vena cava for non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2004-09, Vol.45 (3), p.357-363

2004

Volltextzugriff (PDF)

17 cases of advanced non-small cell lung cancer treated with paclitaxel liposome plus nedaplatin

The Chinese-German journal of clinical oncology, 2012-04, Vol.11 (4), p.196-198

2012

Volltextzugriff (PDF)

IL‐17 induces non‐small cell lung cancer metastasis via GCN5‐dependent SOX4 acetylation enhancing MMP9 gene transcription and expression

Molecular carcinogenesis, 2023-09, Vol.62 (9), p.1399-1416

2023

Volltextzugriff (PDF)

IL-17 induces NSCLC cell migration and invasion by elevating MMP19 gene transcription and expression through the interaction of p300-dependent STAT3-K631 acetylation and its Y705-phosphorylation

Oncology research, 2024, Vol.32 (4), p.625-641

2024

Volltextzugriff (PDF)

IL-17 promoted metastasis of non-small-cell lung cancer cells

Immunology letters, 2012-12, Vol.148 (2), p.144-150

2012

Volltextzugriff (PDF)

IL-17 Promotes Nitric Oxide Production in Non-Small-Cell Lung Cancer

Journal of clinical medicine, 2021-10, Vol.10 (19), p.4572

2021

Volltextzugriff (PDF)

179P Efficacy and safety of extended-interval dosing strategy of immune checkpoint inhibitors during the COVID-19 outbreak: Experience from a single center

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S794-S795

2021

Volltextzugriff (PDF)

IL-17A as a new circulating bioindicator for non-small cell lung cancer diagnosis and prognosis

European review for medical and pharmacological sciences, 2023-12, Vol.27 (24), p.12004

2023

Volltextzugriff (PDF)

IL-17A promotes tumorigenesis and upregulates PD-L1 expression in non-small cell lung cancer

Journal of translational medicine, 2023-11, Vol.21 (1), p.828-828, Article 828

2023

Volltextzugriff (PDF)

17β-Hydroxysteroid Dehydrogenase Type 1 Inhibition: A Potential Treatment Option for Non-Small Cell Lung Cancer

ACS medicinal chemistry letters, 2021-12, Vol.12 (12), p.1920-1924

2021

Volltextzugriff (PDF)

18 F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose

Radiation oncology (London, England), 2012-07, Vol.7 (1), p.106-106, Article 106

2012

Volltextzugriff (PDF)

(18)F-FDG PET/CT for monitoring treatment responses to the epidermal growth factor receptor inhibitor erlotinib

The Journal of nuclear medicine (1978), 2011-11, Vol.52 (11), p.1684-1689

2011

Volltextzugriff (PDF)

(18)F-FDG PET-CT simulation for non-small-cell lung cancer: effect in patients already staged by PET-CT

International journal of radiation oncology, biology, physics, 2010-05, Vol.77 (1), p.24-30

2010

Volltextzugriff (PDF)

IL-18 serves as a main effector of CAF-derived METTL3 against immunosuppression of NSCLC via driving NF-κB pathway

Epigenetics, 2023-12, Vol.18 (1), p.2265625-2265625

2023

Volltextzugriff (PDF)

180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S795-S795

2021

Volltextzugriff (PDF)

1 – 25 von 15.453

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12.864)
Mit Volltextzugriff
(13.908)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

11 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(13.415)
Life Sciences & Biomedicine
(13.198)
Nsclc
(10.466)
Oncology
(8.292)
Humans
(7.532)
Lung Cancer
(5.269)
Lung Neoplasms - Pathology
(3.865)
Female
(3.540)
Carcinoma, Non-Small-Cell Lung - Pathology
(3.520)
Male
(3.481)
Non-Small Cell Lung Cancer
(3.433)
Lung Neoplasms - Drug Therapy
(3.240)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(3.185)
Middle Aged
(2.967)
Respiratory System
(2.949)
Aged
(2.781)
Lung Neoplasms - Genetics
(2.727)
Carcinoma, Non-Small-Cell Lung - Genetics
(2.671)
Non-Small Cell Lung Carcinoma
(2.592)
Tumors
(2.264)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Electronic Journals Library
(9.579)
Ingenta
(7.716)
MEDLINE
(7.615)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(3.992)
IngentaConnect Journals
(3.818)
Elsevier ScienceDirect Journals Complete
(3.108)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(2.255)
SpringerLink Journals - AutoHoldings
(1.964)
Wiley Online Library
(1.265)
Taylor & Francis Journals
(1.193)
NUS Single-Journal Subscriptions
(955)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(922)
Taylor & Francis
(791)
Wiley Online Library Full Collection 2018
(583)
Taylor & Francis Online
(517)
SAGE Journals
(347)
Nexis Uni
(317)
Ebook Central Perpetual and DDA
(180)
eBooks on EBSCOhost
(177)
Nature Journals
(163)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Lung Cancer
(862)
Translational Lung Cancer Research
(579)
Journal Of Thoracic Disease
(509)
Journal Of Thoracic Oncology
(481)
Frontiers In Oncology
(459)
Clinical Lung Cancer
(381)
Cancers
(373)
Oncotarget
(296)
Thoracic Cancer
(206)
Anticancer Research
(201)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

1,2,4-Oxadiazole derivatives targeting EGFR and c-Met degradation in TKI resistant NSCLC

1,3‐diarylpyrazolones as potential anticancer agents for non‐small cell lung cancer: Synthesis and antiproliferative activity evaluation

1‐Monopalmitin promotes lung cancer cells apoptosis through PI3K/Akt pathway in vitro

1-n-heptyl-5-(3, 4-difluorophenyl) biguanide inhibits non-small cell lung cancer cell growth by downregulating the EGFR signaling pathways

1-o-acetylbritannilactone (ABL) inhibits angiogenesis and lung cancer cell growth through regulating VEGF-Src-FAK signaling

1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol treatment inhibits abnormal tumor growth by regulating neutrophil infiltration in a non-small cell lung carcinoma mouse model

A 10‐year prediagnostic follow‐up study shows that serum RNA signals are highly dynamic in lung carcinogenesis

125I Seed Brachytherapy Combined with Single-Agent Chemotherapy in the Treatment of Non-Small-Cell Lung Cancer in the Elderly: A Valuable Solution

14-3-3ζ promotes lung cancer cell invasion by increasing the Snail protein expression through atypical protein kinase C (aPKC)/NF-κB signaling

A 15-min premedication for 1-h paclitaxel infusion: Optimizing patients’ care

15 years single center experience with surgical resection of the superior vena cava for non-small cell lung cancer

17 cases of advanced non-small cell lung cancer treated with paclitaxel liposome plus nedaplatin

IL‐17 induces non‐small cell lung cancer metastasis via GCN5‐dependent SOX4 acetylation enhancing MMP9 gene transcription and expression

IL-17 induces NSCLC cell migration and invasion by elevating MMP19 gene transcription and expression through the interaction of p300-dependent STAT3-K631 acetylation and its Y705-phosphorylation

IL-17 promoted metastasis of non-small-cell lung cancer cells

IL-17 Promotes Nitric Oxide Production in Non-Small-Cell Lung Cancer

179P Efficacy and safety of extended-interval dosing strategy of immune checkpoint inhibitors during the COVID-19 outbreak: Experience from a single center

IL-17A as a new circulating bioindicator for non-small cell lung cancer diagnosis and prognosis

IL-17A promotes tumorigenesis and upregulates PD-L1 expression in non-small cell lung cancer

17β-Hydroxysteroid Dehydrogenase Type 1 Inhibition: A Potential Treatment Option for Non-Small Cell Lung Cancer

18 F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose

(18)F-FDG PET/CT for monitoring treatment responses to the epidermal growth factor receptor inhibitor erlotinib

(18)F-FDG PET-CT simulation for non-small-cell lung cancer: effect in patients already staged by PET-CT

IL-18 serves as a main effector of CAF-derived METTL3 against immunosuppression of NSCLC via driving NF-κB pathway

180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19

Suchergebnisse filtern